Hangzhou, China

Yanfen Li

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Hangzhou Tianlong Pharmaceutical Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yanfen Li. Retrieved from https://idiyas.com/inventor/yanfen-li-fldaxkom

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yanfen Li - Innovator in mRNA Vaccine Development

Introduction

Yanfen Li is a prominent inventor based in Hangzhou, China. She has made significant contributions to the field of vaccine development, particularly in the area of mRNA technology. Her work is crucial in addressing public health challenges.

Latest Patents

Yanfen Li holds a patent for the "HERPES ZOSTER mRNA VACCINE, PREPARATION METHOD THEREFOR, AND USE THEREOF." This innovative vaccine aims to provide effective protection against herpes zoster, showcasing her expertise in mRNA vaccine technology. She has 1 patent to her name.

Career Highlights

Li is currently employed at Hangzhou Tianlong Pharmaceutical Co., Ltd., where she continues to advance her research and development efforts. Her role at the company allows her to collaborate with other experts in the field and contribute to groundbreaking innovations.

Collaborations

Throughout her career, Yanfen Li has worked alongside talented colleagues, including Gengshen Song and Kai Dong. These collaborations have fostered a dynamic environment for innovation and research.

Conclusion

Yanfen Li's contributions to mRNA vaccine development are noteworthy and reflect her dedication to improving public health. Her innovative work continues to pave the way for future advancements in vaccine technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…